This study presents a comparative analysis of the environmental and economic performances of four integrated waste and wastewater management scenarios in the city of Aarhus in Denmark. The purpose of this analysis is to deliver decision support regarding whether (i) the installation of food waste disposers in private homes (AS1) or (ii) separate collection and transport of organic waste to biogas plants is a more viable environmental and economic solution (AS2). Higher environmental benefits, e.g., mitigation of human health impacts and climate change, are obtained by transforming the existing waste combustion system into scenario (ii). Trade-offs in terms of increased marine eutrophication and terrestrial ecotoxicity result from moving up the waste hierarchy; i.e., from waste incineration to biogas production at wastewater treatment plants with anaerobic sludge digestion. Scenario (i) performs with lower energy efficiency compared to scenario (ii). Furthermore, when considering the uncertainty in the extra damage cost to the sewer system that may be associated to the installation of food waste disposers, scenario (ii) is the most flexible, robust, and less risky economic solution. From an economic, environmental, and resource efficiency point of view, separate collection and transport of biowaste to biogas plants is the most sustainable solution.

Drawing the picture of the opportunities and challenges of using in vitro data to calculate effect factors in LCA.

Today's scarcity of animal toxicological data for nanomaterials could be lifted by substituting in vivo data with in vitro data to calculate nanomaterials' effect factors (EF) for Life Cycle Assessment (LCA). Here, we present a step-by-step procedure to calculate in vitro-to-in vivo extrapolation factors to estimate human Benchmark Doses and subsequently in vitro-based EFs for several inhaled nonsoluble nanomaterials. Based on mouse data, the in vitro-based EF of TiO₂ is between 2.76 · 10^-4 and 1.10 · 10^-3 cases/(m²/g·kg intake), depending on the aerodynamic size of the particle, which is in good agreement with in vivo-based EFs (1.51 · 10^-4-5.6 · 10^-2 cases/(m²/g·kg intake)). The EF for amorphous silica is in a similar range as for TiO₂, but the result is less robust due to only few in vivo data available. The results based on rat data are very different, confirming the importance of selecting animal species representative of human responses. The discrepancy between in vivo and in vitro animal data in terms of availability and quality limits the coverage of further nanomaterials. Systematic testing on human and animal cells is needed to reduce the variability in toxicological response determined by the differences in experimental conditions, thus helping improve the predictivity of in vitro-to-in vivo extrapolation factors.